Emris Pharma
unknown
unknown
Stage
About
Develops a topical solution to prevent skin toxicities caused by EGFR inhibitors used in cancer treatment.
Explore Emris Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.